Posters produced in 2013

ERS 2013, European Respiratory Society Annual Congress, SPAIN Barcelona, 2013, September 07 – 11 .On behalf of the ASTRO-LAB group: Eric Van Ganse (MD, PhD). “Assessment of the safety of Long Acting beta-agonists in asthma by combining health care databases and direct patient follow-up : Focus on detailed pattern of use of therapy
ERS 2013, European Respiratory Society Annual Congress, SPAIN Barcelona, 2013, September 07 – 11 .Laforest Laurent, Marine Ginoux, Manon Belhassen, Philippe Ya, Gilles Devouassoux, Nicolas Roche, Christos Chouaid, Eric Van Ganse. “Factors associated with global mortality in COPD between 2006 and 2011: french claims data
ICPE 2013, 29th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, CANADA Montreal, 2013, August 25 – 28 .Laforest Laurent, Marine Ginoux, Manon Belhassen, Philippe Ya, Gilles Devouassoux, Nicolas Roche, Christos Chouaid, Eric Van Ganse. “Changes in therapeutic management of COPD between 2006 and 2011: french claims data
ICPE 2013, 29th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, CANADA Montreal, 2013, August 25 – 28 .Frédéric Aubrun, Manon Belhassen, Catherine Cornu, Emilie Muller, Laurent Letrilliart, François Gueyffier, Laurent Laforest, Elodie Chaissac, Comité douleur-anesthésie loco-régionale, Eric Van Ganse. “Therapeutic consequences of dextropropoxyphene withdrawal in France
ISPOR 2013, 16th annual European congress, IRELAND Dublin, 2013, 2/6 November .Manon Belhassen, Marine Ginoux, Valérie Laigle, Thierry Souchet, Céline Chanut-Vogel, Liliane Lamezec, Jacques de Blic, Jacques Brouard, Brigitte Fauroux, Gérard de Pouvourville, Laurent Laforest, Eric Van Ganse . “Effectiveness of Montelukast on asthma control in infants: methodology of a claims data study
PEP 2013, 6ème Forum Scientifique de Pharmaco-épidémiologie (PEP), FRANCE Paris, 2013, 27 et 28 juin .E. Van Ganse, L. Laforest, I. Licaj, C. Tamberou, G. Devouassoux , G. Chatte, M. Belhassen , G. Chamba. “Relative Exposure To Inhaled Steroids (Ratio “ICS-To-Total Asthma Therapy”) and Patient-Reported Outcomes (PROs): A Survey In Community Pharmacies
PEP 2013, 6ème Forum Scientifique de Pharmaco-épidémiologie (PEP), FRANCE Paris, 2013, 27 et 28 juin .Eric Van Ganse , Sandy Leproust, Laurent Laforest, Olivier Saint-Lary, Alain Mercier, Nathalie Texier and the ASTRO-LAB group. “The ASTRO-LAB project : an European project combining healthcare databases and direct patient follow-up to assess the safety of Long-Acting ß2 Agonists (LABAs) in asthma in routine care
PEP 2013, 6ème Forum Scientifique de Pharmaco-épidémiologie (PEP), FRANCE Paris, 2013, 27 et 28 juin .L. Laforest, J. Martin, I. Licaj, G. Devouassoux, G. Chatte M, E. Van Ganse. “Facteurs associés aux fortes délivrances de bêta agonistes inhalés à courte durée d’action dans l’asthme
PEP 2013, 6ème Forum Scientifique de Pharmaco-épidémiologie (PEP), FRANCE Paris, 2013, 27 et 28 juin .Laurent Laforest, Marie-Sophie Schwalm, Marion Dufour, Alison Bourke, Mélanie Broquet, Eric Van Ganse. “Comparison of prescribing patterns in asthma patients supervised in primary care between five European countries